The major implication of these results for health policymakers is that defenders of traditional “silos” of medicine need to rethink what ought to be considered traditional roles for GPs and pharmacists. Moreover, if pharmacists are going to assume a greater role in the provision of primary care services, then the industry is going to have to think through what training and accommodation will be necessary to give consumers the confidence that these services do not compromise the quality they have come to expect from GPs.
Pharmacists and Primary Health Care Consumer Survey Report
Submission to RACGP Paper: Vision for a Sustainable Health System
Abstract: CHF's submission to the RACGP's Vision for a Sustainable Health System Discussion Paper.
“Unique and essential”: a review of the role of consumer representatives in health decision-making
The aim of this project was to review and assess the evidence that demonstrates the contributions and outcomes of consumer representation on health and medical Boards/Committees, in particular to document the impact of consumer representatives’ contribution to health policies, programs and services.
Submission on the Issues Paper for the Post-market Review of the Life Saving Drugs Programme
The Consumers Health Forum of Australia (CHF) is pleased to provide a submission to the Issues Paper for the Post-Market Review of the Life-Saving Drugs Programme (the Issues Paper). Before going into the content of our views, we want to express our deep concerns with the limitations the Review has given to stakeholders to comment on the Issues Paper.
CHF's First Views on Budget 2015-16
This is an initial analysis of the Federal Health Budget from the Consumers Health Forum of Australia (CHF). There is further detail in the Budget papers that require further appraisal before CHF takes a view on these aspects. We are preparing a more detailed analysis based on further briefings and consultations.
Health Voices, Issue 16, April 2015
PHNs... Will they be good for our health?
Submission to the Senate Community Affairs References Committee Inquiry into the Availability of new, innovative and specialist cancer drugs in Australia
This submission into the Availability of new, innovative and specialist cancer drugs in Australia draws on the experiences of our members and consumer representatives in assessing the availability and effectiveness of medicines in Australia, and in particular the operation of the Pharmaceutical Benefits Advisory Committee (PBAC) and the Pharmaceutical Benefits Scheme (PBS).
Submission to Review of Complementary Medicines - Expert Review of Medicines and Medical Devices Regulation
The definitive goal of this review of the regulatory framework should be the safety and quality of complementary medicines in Australia. Any new framework must carefully balance the risk to consumer safety and consumer choice concerns.
Consumers Shaping Health, vol 9, issue 2, April 2015
CHF's new CEO; Pharmacy deal in urgent need of new script; Health Minister Ley: 'above all, consumer-focused'; Now co-pay is cremated, time to revive Medicare; Asthma Australia conference; In sickness and in health; Why do I even need this test?; "Frequent flyer" claim shown to be a sick joke for many patients; AHHA Think Tank on Reform of the Federation and Health; Life Saving Drugs Programme Review
Consumers Shaping Health, vol 9, issue 1, February 2015
Nothing about us, without us!;Tackling obesity: Australia wants change; Price Signals and Health Hazards; Federal Government must not send medicines safety checks offshore; Thanks and farewell to Adam; The costs of chronic illness; Would you like to be part of Consumers Shaping Health?; Problems with Federal/State buck-passing?